SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001346302-20-000010
Filing Date
2020-03-12
Accepted
2020-03-12 16:27:55
Documents
3
Effectiveness Date
2020-03-12

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 93871
2 EXHIBIT 5.1 s-8exhibit51.htm EX-5.1 8537
3 EXHIBIT 23.1 s-8exhibit231.htm EX-23.1 3598
  Complete submission text file 0001346302-20-000010.txt   107028
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237120 | Film No.: 20709165
SIC: 2834 Pharmaceutical Preparations